UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Heart (British Cardiac Society), ISSN 1355-6037, 05/2011, Volume 97, Issue 10, pp. 797 - 802
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Biological and medical sciences | Medical sciences | Other diseases. Semiology | Esomeprazole - administration & dosage | Humans | Middle Aged | Peptic Ulcer - prevention & control | Male | Anti-Ulcer Agents - administration & dosage | Young Adult | Aspirin - adverse effects | Aged, 80 and over | Adult | Female | Aged | Peptic Ulcer - chemically induced | Prevention | Aspirin | Peptic ulcer | Dosage and administration | Research | Drug therapy | Coronary heart disease | Studies | Disease prevention | Stroke | Heart attacks | Ulcers | Coronary vessels | Mortality | Cardiovascular disease | Infections | Clinical medicine | Endoscopy | Acute coronary syndromes | Index Medicus | Abridged Index Medicus | esomeprazole | Clinical Trials | 1506 | acetylsalicylic acid | cardiovascular risk management
Journal Article
The American journal of gastroenterology, ISSN 0002-9270, 03/2009, Volume 104, Issue 3, pp. 728 - 738
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Anti-Ulcer Agents - therapeutic use | Peptic Ulcer - complications | Humans | Risk Factors | Peptic Ulcer Hemorrhage - chemically induced | Peptic Ulcer - prevention & control | Helicobacter Infections - complications | Anticoagulants - adverse effects | Proton Pump Inhibitors - therapeutic use | Histamine H2 Antagonists - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Helicobacter pylori | Aspirin - adverse effects | Cyclooxygenase 2 Inhibitors - therapeutic use | Peptic Ulcer Hemorrhage - prevention & control | Peptic Ulcer - chemically induced | Misoprostol - therapeutic use | Index Medicus
Journal Article
Annals of internal medicine, ISSN 0003-4819, 04/2009, Volume 150, Issue 7, pp. 455 - 464
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Public health. Hygiene-occupational medicine | Public health. Hygiene | General aspects | Prevention and actions | Biological and medical sciences | Medical sciences | Other diseases. Semiology | Proton Pump Inhibitors - adverse effects | Injections, Intravenous | Esomeprazole - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Esomeprazole - adverse effects | Male | Combined Modality Therapy | Secondary Prevention | Peptic Ulcer Hemorrhage - therapy | Retreatment | Proton Pump Inhibitors - administration & dosage | Hemostasis, Endoscopic - methods | Peptic Ulcer Hemorrhage - prevention & control | Aged, 80 and over | Adult | Female | Aged | Infusions, Intravenous | Prevention | Complications and side effects | Peptic ulcer | Diagnosis | Drug therapy | Hemorrhage | Risk factors | Inhibitor drugs | Ulcers | Multiracial people | Gastroenterology | Index Medicus | Abridged Index Medicus
Journal Article
Journal of gastroenterology, ISSN 0944-1174, 6/2015, Volume 50, Issue 6, pp. 638 - 644
Eradication therapy | Medicine & Public Health | Helicobacter pylori | Colorectal Surgery | Hepatology | Gastroenterology | Abdominal Surgery | Surgical Oncology | Gastric cancer | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Peptic Ulcer - complications | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Helicobacter Infections - complications | Male | Young Adult | Peptic Ulcer - microbiology | Time Factors | Helicobacter Infections - drug therapy | Stomach Neoplasms - prevention & control | Adolescent | Aged, 80 and over | Adult | Female | Stomach Neoplasms - epidemiology | Aged | Helicobacter pylori - isolation & purification | Peptic Ulcer - drug therapy | Cohort Studies | Prevention | Care and treatment | Cancer patients | Analysis | Oncology, Experimental | Peptic ulcer | Development and progression | Helicobacter infections | Research | Stomach cancer | Cancer | Index Medicus
Journal Article
Alimentary pharmacology & therapeutics, ISSN 0269-2813, 03/2008, Volume 27, Issue 6, pp. 465 - 472
Gastroenterology & Hepatology | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Biological and medical sciences | Medical sciences | Digestive system | Pharmacology. Drug treatments | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Peptic Ulcer - classification | Humans | Peptic Ulcer - diagnosis | Peptic Ulcer - prevention & control | Terminology as Topic | Clinical Trials as Topic | Peptic Ulcer - chemically induced | Clinical trials | Nonsteroidal anti-inflammatory drugs | Index Medicus
Journal Article
Critical care medicine, ISSN 0090-3493, 07/2016, Volume 44, Issue 7, pp. 1395 - 1405
histamine-2-receptor antagonist | stress ulcer prophylaxis | intensive care | critically ill | proton pump inhibitor | hemorrhage | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Gastrointestinal Hemorrhage - prevention & control | Cost-Benefit Analysis | Humans | Stress, Physiological | Critical Illness | Peptic Ulcer - prevention & control | Critical Care | Proton Pump Inhibitors - therapeutic use | Histamine H2 Antagonists - therapeutic use | Practice Guidelines as Topic | Index Medicus | Abridged Index Medicus
Journal Article
Annals of internal medicine, ISSN 0003-4819, 01/2010, Volume 152, Issue 1, pp. 1 - 9
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Biological and medical sciences | General aspects | Medical sciences | Other diseases. Semiology | Recurrence | Cardiovascular Diseases - prevention & control | Humans | Male | Aspirin - administration & dosage | Cerebrovascular Disorders - prevention & control | Aspirin - adverse effects | 2-Pyridinylmethylsulfinylbenzimidazoles - therapeutic use | Platelet Aggregation Inhibitors - administration & dosage | Aged, 80 and over | Gastrointestinal Hemorrhage - therapy | Female | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Anti-Ulcer Agents - therapeutic use | Double-Blind Method | Drug Administration Schedule | Risk Factors | Endoscopy, Gastrointestinal | Proton Pump Inhibitors - therapeutic use | Gastrointestinal Hemorrhage - chemically induced | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Peptic Ulcer - therapy | Hemostatic Techniques | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Aged | Peptic Ulcer - chemically induced | Complications and side effects | Aspirin | Peptic ulcer | Dosage and administration | Research | Drug therapy | Hemorrhage | Risk factors | Clinical trials | Ulcers | Index Medicus | Abridged Index Medicus
Journal Article
Drugs & aging, ISSN 1170-229X, 2007, Volume 24, Issue 10, pp. 815 - 828
Cyclo oxygenase 2 inhibitors | Nonsteroidal anti inflammatories | Peptic ulcer | Bleeding ulcer | Helicobacter pylori eradication therapies | Proton pump inhibitors | Misoprostol | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Geriatrics/Gerontology | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Geriatrics & Gerontology | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Skin, nail, hair, dermoskeleton | Blood. Blood coagulation. Reticuloendothelial system | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Other diseases. Semiology | Peptic Ulcer Hemorrhage - microbiology | Humans | Risk Factors | Helicobacter pylori - pathogenicity | Peptic Ulcer Hemorrhage - chemically induced | Helicobacter Infections - complications | Cyclooxygenase 2 Inhibitors - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Helicobacter Infections - drug therapy | Peptic Ulcer Hemorrhage - prevention & control | Peptic Ulcer Hemorrhage - epidemiology | Aged | Helicobacter Infections - microbiology | Index Medicus
Journal Article
The American journal of gastroenterology, ISSN 0002-9270, 03/2012, Volume 107, Issue 3, pp. 345 - 360
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Fluid Therapy | Meta-Analysis as Topic | Prognosis | Resuscitation - methods | Risk Assessment | Humans | Endoscopy, Gastrointestinal | Clinical Trials as Topic | Secondary Prevention | Erythromycin - therapeutic use | Evidence-Based Medicine | Proton Pump Inhibitors - therapeutic use | Patient Selection | Peptic Ulcer Hemorrhage - therapy | Retreatment | Blood Transfusion | Hemostasis, Endoscopic - methods | Gastric Lavage | Peptic Ulcer Hemorrhage - diagnosis
Journal Article